NDT Advance Access originally published online on July 27, 2004
Nephrology Dialysis Transplantation 2004 19(9):2325-2333; doi:10.1093/ndt/gfh316
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nephrol Dial Transplant Vol. 19 No. 9 © ERA-EDTA 2004; all rights reserved
Original Article
Can blood flow surveillance and pre-emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study
1 Divisione di Nefrologia, 2 Dipartimento di Scienze Chirurgiche, 3 Dipartimento di Medicina e Sanità Pubblica and 4 Istituto di Radiologia, Verona, Italy
Correspondence and offprint requests to: Nicola Tessitore, Divisione di Nefrologia – Servizio Emodialisi Ospedale Policlinico, Università di Verona, Piazzale L.A. Scuro 10, Verona 37126, Italy. Email: nicola.tessitore{at}azosp.vr.it
Background. Stenosis is the main cause of arteriovenous fistula (AVF) failure. It is unclear, however, if surveillance for stenosis enhances AVF function and longevity and if there is an ideal time for intervention.
Methods. In a 5-year randomized, controlled, open trial we compared blood flow surveillance and pre-emptive repair of subclinical stenoses (one or both of angioplasty and open surgery) with standard monitoring and intervention based upon clinical criteria alone to determine if the former prolonged the longevity of mature forearm AVFs. Surveillance with blood pump flow (Qb) monitoring during dialysis sessions and quarterly shunt blood flow (Qa) or recirculation measurements identified 79 AVFs with angiographically proven, significant (>50%) stenosis. The AVFs were randomized to either a control group (intervention done in response to a decline in the delivered dialysis dose or thrombosis; n = 36) or to a pre-emptive treatment group (n = 43). To evaluate a possible relationship between outcome and haemodynamic status of the access, AVFs were divided into functional and failing subgroups, according to Qa values higher or lower than 350 ml/min or the absence or presence of recirculation.
Results. A Kaplan–Meier analysis showed that pre-emptive treatment reduced failure rate (P = 0.003) and the Cox hazards model identified treatment (P = 0.009) and higher baseline Qa (P = 0.001) as the only variables associated with favourable outcome. Primary patency rates were higher in treatment than in control AVFs in both functional (P = 0.021) and failing subgroups (P = 0.005). They were also higher in functional than in failing AVFs in both control (P<0.001) and treatment groups (P = 0.023). Access survival was significantly higher in pre-emptively treated than in control AVFs (P = 0.050), a higher post-intervention Qa being the only variable associated with improved access longevity (P = 0.044). Secondary patency rates were similar in pre-emptively treated and control AVFs in both functional (P = 0.059) and failing subgroups (P = 0.394). They were also similar in functional and failing AVFs in controls (P = 0.082), but were higher in pre-emptively treated functional AVFs than in pre-emptively treated failing AVFs (P = 0.033) or in the entire control group (P = 0.019).
Conclusions. We provide evidence that active blood flow surveillance and pre-emptive repair of subclinical stenosis reduce the thrombosis rate and prolong the functional life of mature forearm AVFs. We also show that Qa is a crucial indicator of access patency and a Qa >350 ml/min portends a superior outcome with pre-emptive action in AVFs.
Keywords: access blood flow rate; angioplasty; arteriovenous fistula; stenosis; surgery; thrombosis
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. A. Scaffaro, J. A. Bettio, S. A. Cavazzola, B. T. Campos, J. E. Burmeister, R. M. Pereira, C. S. Barcellos, and P. Caramori Maintenance of Hemodialysis Arteriovenous Fistulas by an Interventional Strategy: Clinical and Duplex Ultrasonographic Surveillance Followed by Transluminal Angioplasty J. Ultrasound Med., September 1, 2009; 28(9): 1159 - 1165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. M. Duijm, E. H. Overbosch, Y. S. Liem, R. N. Planken, J. H. M. Tordoir, P. W. M. Cuypers, P. Douwes-Draaijer, and M. W. de Haan Retrograde catheterization of haemodialysis fistulae and grafts: angiographic depiction of the entire vascular access tree and stenosis treatment Nephrol. Dial. Transplant., February 1, 2009; 24(2): 539 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Tessitore, V. Bedogna, A. Poli, W. Mantovani, G. Lipari, E. Baggio, G. Mansueto, and A. Lupo Adding access blood flow surveillance to clinical monitoring reduces thrombosis rates and costs, and improves fistula patency in the short term: a controlled cohort study Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3578 - 3584. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J.T. Huijbregts, M. L. Bots, C. H.A. Wittens, Y. C. Schrama, F. L. Moll, P. J. Blankestijn, and on behalf of the CIMINO study group Hemodialysis Arteriovenous Fistula Patency Revisited: Results of a Prospective, Multicenter Initiative Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 714 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Al-Ghonaim, B. J. Manns, D. J. Hirsch, Z. Gao, M. Tonelli, and for the Alberta Kidney Disease Network Relation between Access Blood Flow and Mortality in Chronic Hemodialysis Patients Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 387 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. Polkinghorne, K. K. P. Lau, A. Saunder, R. C. Atkins, and P. G. Kerr Does monthly native arteriovenous fistula blood-flow surveillance detect significant stenosis--a randomized controlled trial Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2498 - 2506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Tessitore, G. Mansueto, G. Lipari, V. Bedogna, S. Tardivo, E. Baggio, D. Cenzi, G. Carbognin, A. Poli, and A. Lupo Endovascular versus Surgical Preemptive Repair of Forearm Arteriovenous Fistula Juxta-Anastomotic Stenosis: Analysis of Data Collected Prospectively from 1999 to 2004 Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 448 - 454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Jindal, C. T. Chan, C. Deziel, D. Hirsch, S. D. Soroka, M. Tonelli, and B. F. Culleton CHAPTER 4: Vascular Access J. Am. Soc. Nephrol., March 1, 2006; 17(3_suppl_1): S16 - S23. [Full Text] [PDF]
|
|
|
|
|
|
C. D. Cipleu, G. V. Cherla, D. Merrill, and A. Asif Can blood flow surveillance and pre-emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study Nephrol. Dial. Transplant., January 1, 2005; 20(1): 241 - 242. [Full Text] [PDF]
|
|
|
|
|
|
N. Tessitore, G. Lipari, A. Poli, V. Bedogna, E. Baggio, and G. Mansueto Reply Nephrol. Dial. Transplant., January 1, 2005; 20(1): 242 - 243. [Full Text] [PDF]
|
|